Isaac E. Ciechanover, Chief Executive Officer at Atara Biotherapeutics, Inc. (ATRA), sold 2,100 shares at $38.59 ($81K) on 2019-03-28, disclosed to the SEC on 2019-04-01.
Scheduled sale ($81k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.02 | 1,600 | $61K | 75.3% |
| 2 | $38.59 | 300 | $12K | 14.3% |
| 3 | $41.70 | 200 | $8K | 10.3% |
| Total | $38.45 avg | 2,100 | $81K | 100% |
| Filing → |
| ATRA | SELL | 2019-04-29 | $262K | — | Filing → |
| ATRA | SELL | 2019-04-12 | $286K | — | Filing → |
| ATRA | SELL | 2019-03-18 | $437K | — | Filing → |